ATS 2013
The American Thoracic Society (ATS) will hold its 2013 International Conference May 17-22 in Philadelphia, PA. ATS 2013 will focus on subjects including pulmonary care, critical care, sleep medicine, and more. According to ATS, the conference will show attendees the connections between basic, translational, and clinical research.
Day 1
Dr. Colin Cooke Discusses the Affordable Care Act's Impact on Patient Outcomes
"I think probably most importantly, the Affordable Care Act (ACA) seeks to expand insurance coverage for a large population of people," said Colin Cooke, MD, MSc, Assistant Professor of Medicine, University of Michigan, Ann Arbor, MI.
Dr. David Weidig Addresses Discharge Planning Initiatives in Pulmonary Medicine
David Weidig, MD, System Director of Hospital Medicine, Aurora Medical Group, Milwaukee, WI, says that readmissions are not necessarily a failure of medical treatment, but a failure of psycologic and social support systems for the patient that are not addressed while the patient is hospitalized.
Hospital Readmissions: Challenges in Pulmonary Medicine Practice - Part 1
David H. Au, MD, MS, kicked off the Hospital Readmissions session at the American Thoracic Society 2013 conference with his presentation on Defining the Role of the Practitioner, Scientist and Policymaker. In the presentation, Dr Au says that it is important for all stakeholders in the healthcare industry to focus on hospital readmission rates.
When Conventional Drugs Aren't Enough: Enhancing the Immune System in Pulmonary Infections
Dr Keertan Dheda's presentation at the American Thoratic Society 2013 International Conference, XDR TB: What Else Can We Do? focused on the growing epidemic of drug resistant tuberculosis (DR TB). Dr Dheda said there are about 25000 XDR TB global cases annually, and that DR TB can be very expensive to treat and manage.
Day 2
Dr. Gulshan Sharma Discusses the Hospitalist Movement
In this video, Gulshan Sharma, MD, MPH, Associate Professor, University of Texas Medical Branch, Galveston, TX, addresses the hospitalist movement, which has resulted in shorter hospital stays and lower costs of care.
Dr. David Au Talks About Integrated Approaches to Systems of Care
David Au, MD, Professor, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, says that hospital systems represent only one aspect of care delivery for patients who have been hospitalized.
Hospital Readmissions: Challenges in Pulmonary Medicine Practice - Part 2
The panel at the American Thoracic Society 2013 International Conference continued discussions that suggested high rates of hospital readmissions may be an indicator of poor initial treatment, or failure to coordinate care. Further, these rates, which varied dramatically from hospital to hospital, were often excessively expensive.
Choosing Wisely: Top Ways to Reduce Low-Value Care in Pulmonary and Critical Care
Scott Halpern, MD, PhD, discussed the Choosing Wisely campaign with his opening presentation on The History of and Rationale for the Choosing Wisely Campaign. As most healthcare providers know, healthcare spending per capita in the United States is significantly higher than most other countries.
Day 3
Dr. Colin Cooke Highlights Healthcare Reform's Effects on Pulmonary Medicine
Colin Cooke, MD, MSc, Assistant Professor of Medicine, University of Michigan, Ann Arbor, MI, says that hospitals with higher readmission rates that treat patients with acute myocardial infarction, congestive heart failure, and pneumonia will be penalized due to healthcare reform.
Dr Richard Channick, MD, Discusses Clinical Trial in Pulmonary Hypertension
Richard Channick, MD, Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital, Boston, MA, spoke at the 2013 American Thoracic Society International Conference as part of a session featuring the Clinical Trials in Pulmonary Hypertension.
Dr. Richard Channick Addresses a New Treatment in Pulmonary Arterial Hypertension
In this video, Richard Channick, MD, Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital, Boston, MA, speaks about the use of Macitentan for the treatment of pulmonary arterial hypertension (PAH).
The Affordable Care Act: Implications for Clinical Practice and Research
In "What Does the Affordable Care Act Actually Do?," presented by Ivor Douglas, MD, Associate Professor, University of Colorado Denver, Chief, Pulmonary Sciences and Critical Care Medicine Director, Medical Intensive Care, Denver Health Medical Center, at the ATS 2013 International Conference, Dr Douglas noted that fundamental issues driving the Affordable Care Act (ACA) include access, quality, and cost.